The availability of radioactive isotopes of iron led to the development of reliable methods of studying iron kinetics (1), but the absorption of iron by the gastrointestinal tract was still determined indirectly by the amount of unabsorbed iron excreted in the stools or by quantification of isotopic iron incorporated into hemoglobin (2-7). The availability of a whole-body counter in a clinical facility has made possible the direct assay of iron59 retention in human subjects and has eliminated sample collecting and preparation. The purpose of this paper is to describe this method and demonstrate some of the findings.
The availability of radioactive isotopes of iron led to the development of reliable methods of studying iron kinetics (1) , but the absorption of iron by the gastrointestinal tract was still determined indirectly by the amount of unabsorbed iron excreted in the stools or by quantification of isotopic iron incorporated into hemoglobin (2) (3) (4) (5) (6) (7) . The availability of a whole-body counter in a clinical facility has made possible the direct assay of iron59 retention in human subjects and has eliminated sample collecting and preparation. The purpose of this paper is to describe this method and demonstrate some of the findings.
METHODS AND MATERIALS
Thirty-five volunteers, 25 normal and 10 iron-deficient adults, were the subj ects of the study. The iron-deficient subjects met one or more of the following criteria: 1) virtual absence of iron in bone marrow smears stained by the Prussian-blue reaction (8) ; 2) serum iron less than 70 Ag per 100 ml with total iron-binding capacity in excess of 350 jig (9, 10) ; 3) recent loss of blood without replacement by iron or transfusion. Five subjects (Tables IV and V, numbers 1, 3, 4, 7 and 9) had been purposely phlebotomized to induce iron deficiency. They were in various stages of recovery following the loss of 4 or 5 units (2.0 to 2.5 L) of blood in a period of 1 month. In Subjects 4 and 9 the peripheral parameters had become normal at a time when one could be sure from the history, amount of blood loss and the lack of iron in the marrow, that the body iron stores had not been replenished.
The normal iron-replete subj ects met none of these criteria. Serum iron was in excess of 80 ,ug per 100 ml; there was no evidence of bleeding or history of recent blood loss. Red cell indices were established in all subjects. None of the subjects was known to have neoplastic, infectious or inflammatory disease.
Iron absorption studies were performed in each subject with radioactive iron' and a whole-body liquid scintillation counter. The instrument was a 47r liquid scintillation counter simliar in design to the Los Alamos counter (11) . The major differences were an increase in diameter of the sample well to 20 inches and the substitution of thirty 5-inch photocathode tubes. This instrument was operated as a two-channel analyzer, specifically to detect body cesium.. and potassium' with maximal efficiency. The two ranges of -y-energy discrimination were wide (0.3 to 0.8 and 0.8 to 2.0 Mev) and useful for detecting a large number of y-emitting nuclides with good efficiency.
The standards used were a 2.5 L water-filled plastic bottle to which iron" was added in amounts equal to half the dose given the subject. A 250 ml plastic bottle similarly prepared was used as a standard for measurement of radioactivity in feces.
Prior to administration of the radionuclide, the volunteers were assayed in the body counter. They lay supine on a canvas sling within the sample chamber ( Figure 1 For two weeks after ingestion of the iron, 9 of the subjects made complete collections of feces and 3 made complete collections of urine. These were counted in the whole-body counter.
In the beginning of the study, 4 subjects were counted at intervals of 20 to 30 minutes until they had attained a maximal count rate. This occurred from 3 to 4 hours after ingestion of the iron5. Subsequently, the remaining subj ects were assayed 4 hours after the test dose. The explanation for this phenomenon is that, immediately after oral administration, the dose of radioisotope is comparable with a point source surrounded by a large mass of tissue which acts as shielding. After several hours the radioisotope is more widely distributed in the gastrointestinal tract and body. It is then a diffuse source with relatively less shielding and produces a higher count rate. Failure to consider this phenomenon may result in errors of 5 to 10 per cent in calculating the initial retention values. In the third to fifth hour period, count rates vary by 2 per cent or less.
After each count of the subject the standard was also counted. The counts of the subjects and standard were corrected for resolving time loss (12) . The ratio of the subject's count to that of the reference standard, 4 hours after administration of the radionuclide, was used as the 100 per cent reference value. Thereafter any comparison of a similar fraction to the reference value represented the fraction of radionuclide retained by the body at that time. Similarly when fecal excretion was followed, fecal samples were assayed with the appropriate standards.
Fecal count rate/standard count rate X 100 = %o excreted; 100 -% excreted = % retained.
The whole-body liquid scintillation counter was a 47r counting system in which low levels of R-emitting isotopes can be detected. The statistical precision and stability of this type of instrument has been previously reported (11) . The y-energy of iron'9 can be detected in the channel that measures potassium. Detailed calibration of the whole-body counter for iron' led to determination of absolute efficiencies for standards and subjects of various sizes, ranging in weight from 1 to 78 kg. Radioactivity in a large mass was less efficiently de- tected because of self-absorption. A log-log plot of the of iron' and amount of circulating irors removed by data provided a linear relationship between detector phlebotomy were calculated by using the power function efficiency and sample weight, and a least squares analy-and the simple ratios, and the results were compared sis of the data yielded a power function ( Figure 2 ). (Table I ). The efficiency of the subjects was about 12 per cent.
RESULTS
In the clinical studies absolute calibrations were not necessary. It (Table III) . The procedure provided a clear-cut distinction between normal and iron-deficient subjects. The gradual decay of radioactivity after ingestion of the test dose was due to loss of unabsorbed iron in the feces. After loss in the feces stopped, the retention value remained constant, indicating no excretion of the absorbed iron (Tables IV and  V) . However, with chronic loss of blood, there was a corresponding loss of radioactivity.
The accuracy with which blood loss can be quantitated is shown in Figure 3 . The curve is that of a chronic blood donor (number 8, Tables  III and V) . When iron59 retention had reached equilibrium, 500 ml of whole blood was removed on three occasions at weekly intervals. shown to have depleted marrow stores of iron. Phlebotomies of 500 ml each, 21, 28, and 35 days after administration of an oral dose of radioactive iron59 showed an abrupt loss of labeled iron from the body. but larger doses of iron59 would be required. Cumulative urine collections in three subjects contained less than 1 per cent of the administered dose. This confirmed in humans the previous ohservations in animals that significant quantities of radioactive iron are not excreted in the urine (13, 14 
